| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/28/2002 | EP1234576A1 Us0027324for eating disorders |
| 08/28/2002 | EP1234574A1 Hair growth stimulant |
| 08/28/2002 | EP1234573A1 Anti-inflammatory pharmaceutical compositions and their manufacturing process |
| 08/28/2002 | EP1234571A1 Topical composition containing a hydroxystilbene and a polyol |
| 08/28/2002 | EP1234508A1 Antiprotozoal methods, compositions and feedstuffs |
| 08/28/2002 | EP1234048A2 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 08/28/2002 | EP1234043A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/28/2002 | EP1234037A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 08/28/2002 | EP1234030A2 18 human secreted proteins |
| 08/28/2002 | EP1234027A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233983A2 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 08/28/2002 | EP1233980A2 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 08/28/2002 | EP1233975A1 29 human secreted proteins |
| 08/28/2002 | EP1233973A1 Partial or full a1 agonists - n6 heterocyclic 5'-thio substituted adenosine derivatives |
| 08/28/2002 | EP1233972A2 6- i O /i -METHYLERYTHROMYCIN A CRYSTAL FORM III |
| 08/28/2002 | EP1233971A2 6-o-alkyl-2-nor-2-substituted ketolide derivatives |
| 08/28/2002 | EP1233968A2 Transition metal-cyclopentadienyl-tropane conjugates |
| 08/28/2002 | EP1233966A1 Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
| 08/28/2002 | EP1233965A1 Isoquinoline and quinazoline derivatives for the treatment of cns disorders |
| 08/28/2002 | EP1233964A1 New use and novel n-azabicyclo-amide derivatives |
| 08/28/2002 | EP1233963A2 Novel sulfonyl oxazole amines |
| 08/28/2002 | EP1233962A2 Novel heterocyclic compounds and their use as medicines |
| 08/28/2002 | EP1233960A2 Polymorphic salt of an anti-migraine drug |
| 08/28/2002 | EP1233959A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 08/28/2002 | EP1233958A1 Inhibitors of histone deacetylase |
| 08/28/2002 | EP1233957A1 Novel amidine derivatives, preparation and use thereof as medicines |
| 08/28/2002 | EP1233956A1 Bryostatin analogues, synthetic methods and uses |
| 08/28/2002 | EP1233954A1 A process for the preparation of 2- 4-(alpha-phenyl-p-chlorobenzyl)piperazin-1-yl]ethoxy acetic acid and novel intermediates therefor |
| 08/28/2002 | EP1233953A1 Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/28/2002 | EP1233952A1 Pesticidal n-heteroaryl alpha-alkoximino-carboxamides |
| 08/28/2002 | EP1233951A1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 08/28/2002 | EP1233950A1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/P39 kINASE INHIBITORS |
| 08/28/2002 | EP1233949A2 5-substituted arylpyrimidines |
| 08/28/2002 | EP1233948A1 Stable polymorph of n-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof |
| 08/28/2002 | EP1233945A1 Heterocyclic ketone and thioester compounds and uses |
| 08/28/2002 | EP1233943A2 Ionizable indolinone derivatives and their use as ptk ligands |
| 08/28/2002 | EP1233942A2 Treatment of inflammatory bowel disease with vitamin d compounds |
| 08/28/2002 | EP1233815A1 Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension |
| 08/28/2002 | EP1233811A2 Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use |
| 08/28/2002 | EP1233794A1 A bioabsorbable drug delivery system |
| 08/28/2002 | EP1233790A2 A33 antigen specific immunoglobulin products in cancer therapy |
| 08/28/2002 | EP1233789A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids |
| 08/28/2002 | EP1233788A2 Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan |
| 08/28/2002 | EP1233787A1 Product inhibiting transduction of g heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment |
| 08/28/2002 | EP1233786A2 Product comprising at least a no synthase inhibiting substance associated with at least a phospholipase a2 inhibiting substance |
| 08/28/2002 | EP1233782A2 Eliciting hcv-specific antibodies |
| 08/28/2002 | EP1233780A1 Identification of sortase gene |
| 08/28/2002 | EP1233772A1 Boron compounds and complexes as anti-inflammatory agents |
| 08/28/2002 | EP1233771A1 Protease inhibitors |
| 08/28/2002 | EP1233770A2 Phosphonate compounds |
| 08/28/2002 | EP1233769A1 Novel compounds |
| 08/28/2002 | EP1233768A1 Carvedilol methanesulfonate |
| 08/28/2002 | EP1233767A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 08/28/2002 | EP1233766A1 Use of synergistic combinations of a nk 1? receptor antagonist and a gaba analog in psychiatric disorders |
| 08/28/2002 | EP1233765A1 TREATMENT OF EOSINOPHIL ASSOCIATED PATHOLOGIES BY MODULATING PKC-$g(d) ACTIVITY |
| 08/28/2002 | EP1233764A1 Transdermal device comprising a reservoir and a matrix containing the same active principle |
| 08/28/2002 | EP1233763A1 Transdermal therapeutic systems with improved stability and a method for the production thereof |
| 08/28/2002 | EP1233761A1 Osmotic dosage form comprising first and second coats |
| 08/28/2002 | EP1233758A2 Cassette-shaped constructional units in a rotary printing machine |
| 08/28/2002 | EP1233757A2 Aerosol composition comprising formoterol |
| 08/28/2002 | EP1233756A1 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 08/28/2002 | EP1233753A1 Composition and method for treatment of otitis media |
| 08/28/2002 | EP1233748A1 Retinaldehyde combination with antifungal activity |
| 08/28/2002 | EP1233747A2 Use of flavones and/or isoflavones from plant extracts |
| 08/28/2002 | EP1233746A1 Use of a buffer to prevent candida albicans infections on the skin |
| 08/28/2002 | EP1233681A1 Phytosterol and phytostanol compositions |
| 08/28/2002 | EP1233670A1 Nitric oxide donors for inducing neurogenesis |
| 08/28/2002 | EP1140898B1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
| 08/28/2002 | EP1131336B1 Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 |
| 08/28/2002 | EP1123092B1 Fumaric acid microtablets |
| 08/28/2002 | EP1082114B1 Hydroxyomeprazole compositions and uses |
| 08/28/2002 | EP1073653B1 Novel 2-heterocyclically substituted dihydropyrimidines |
| 08/28/2002 | EP1071702B1 Fatty acid derivatives of bile acids and bile acid derivatives |
| 08/28/2002 | EP1054874B1 Substituted aminophenyl isoxazoline derivatives useful as antimicrobials |
| 08/28/2002 | EP1051411B1 Methods for separating a tocol from a tocol-containing mixture |
| 08/28/2002 | EP1040106B1 Carboxyl substituted chroman derivatives useful as beta 3 adrenoreceptor agonists |
| 08/28/2002 | EP1021438A4 Trioxane dimer compounds having antiproliferative and antitumor activities |
| 08/28/2002 | EP1005374A4 Microparticles for delivery of nucleic acid |
| 08/28/2002 | EP1005347A4 Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases |
| 08/28/2002 | EP0988300B1 Benzo(5,6)cyclohepta(1,2-b)pyridine derivatives for the inhibition of farnesyl protein transferase |
| 08/28/2002 | EP0983275B1 Novel triptolide derivatives useful in the treatment of autoimmune diseases |
| 08/28/2002 | EP0981532B1 Acyclovir diester derivatives |
| 08/28/2002 | EP0974350B1 External preparation containing tranilast and process for producing the same |
| 08/28/2002 | EP0973731B1 Hydroxamic acid derivatives |
| 08/28/2002 | EP0973524B1 Cosmetic or dermatological use of 7-hydroxylated steroids |
| 08/28/2002 | EP0933995A4 Method of treating endothelial injury |
| 08/28/2002 | EP0928191B1 Pharmaceutical compositions comprising s-alkylisothiouronium derivatives |
| 08/28/2002 | EP0918777B1 SELECTED DERIVATIVES OF K-252a |
| 08/28/2002 | EP0918759B1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 08/28/2002 | EP0897386B1 Process for the preparation of a magnesium salt of a substituted sulphinyl heterocycle |
| 08/28/2002 | EP0892804B1 Isoxazolidine derivatives |
| 08/28/2002 | EP0869785B1 4-hydroxycoumarin-3-carboxamides for the treatment of non-insulin dependent diabetes mellitus |
| 08/28/2002 | EP0856001B1 Pyrimidine derivatives as 5ht2c receptor antagonists |
| 08/28/2002 | EP0848696B1 2,4-pentadienoic acid derivatives having retinoid-like biological activity |
| 08/28/2002 | EP0846110B1 Thf-containing sulfonamide inhibitors of aspartyl protease |
| 08/28/2002 | EP0827591B1 Method for diagnosing chlamydia using an extracellular biological fluid |
| 08/28/2002 | EP0819002B1 USE OF IMIDAZO-[1,2-a]PYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA |
| 08/28/2002 | EP0806956B1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment |
| 08/28/2002 | EP0806933B1 Formulations and methods for reducing skin irritation |
| 08/28/2002 | EP0800387B1 Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours |